Sign in
CompletedNo phase

Uterine and Endometrial Volume in PCOS and HPOD

Key facts

Who runs it
Jagiellonian University
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
648 people enrolled
Started
5 Jan 2024
Ended
31 Dec 2024
Type of study
Observational, 2 groups
Treatments tested
  • Two-dimensional and three-dimensional ultrasound of the female reproductive organ
Record updated
19 March 2026

Who can take part

Age
18 years to 45 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • age 18-45 years
  • no previous diagnosis and treatment due to menstrual disorders or infertility

Who cannot take part

  • previous ovarian surgery
  • use of drugs that disturb the functions of the hypothalamic-pituitary-ovarian axis
  • uterine tumors

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Group II causes of anovulation according to the World Health Organization include polycystic ovary syndrome (PCOS) and the less common dysfunction of the hypothalamic-pituitary-ovarian axis (HPOD). Assessment of ovarian volume, number and morphology of ovarian follicles is essential in the diagnosis of menstrual disorders, including PCOS and HPOD. However, the uterus is a target organ for steroid hormones, and the assessment of uterine size and endometrial morphology may also be of clinical importance. While ultrasonographic features of the ovaries in PCOS have been described and constitute one of the diagnostic criteria for the syndrome (Rotterdam criteria), there is little data on uterine volume in women with PCOS and HPOD. The aim is to compare ultrasound i) uterine volume and ii) endometrial volume among women with PCOS and women with HPOD.

The 2 groups in the trial

  • Arm 1

    Polycystic ovary syndrome (PCOS)

    Treatment: Two-dimensional and three-dimensional ultrasound of the female reproductive organ

  • Arm 2

    Hypothalamic-pituitary-ovarian axis dysfunction (HPOD)

    Treatment: Two-dimensional and three-dimensional ultrasound of the female reproductive organ

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Ultrasound Assessment of Uterine and Endometrium Volume in Women With PCOS and HPOD
Record updated
19 March 2026